Featured News Image News Features | Jul 10 2025 Stanford H&S Foundational research on brain development may help prevent degeneration Stanford neurobiologist Carla Shatz, famous for discovering how neural connections develop early in life, is using that knowledge to work on the problem of how they can later deteriorate from Alzheimer’s disease. Image Research news | Jul 9 2025 Stanford Medicine People with ‘young brains’ outlive ‘old-brained’ peers A blood-test analysis developed at Stanford Medicine can determine the “biological ages” of 11 separate organ systems in individuals’ bodies and predict the health consequences. Image Researcher profiles | Jun 23 2025 Stanford Report ‘You can literally lose who you are’ Scientists in the lab of chemical engineer Monther Abu-Remaileh are uncovering the cellular functions that go awry in degenerative brain disorders and identifying therapies that could treat them. Image News Features | Jun 17 2025 Wu Tsai Neurosciences Institute Myelin matters A decade ago, three generations of Stanford scientists banded together to publish a landmark study on one of the brain’s most prevalent structures. Today, Wu Tsai Neurosciences Institute researchers are discovering that myelin is key to just about every aspect of neurological health. News Filter & Sort Sort by ThemeNeuroHealth NeuroDiscovery News TypePodcast episodes Press coverage Research news Sort by Newest to oldest Oldest to newest Image Podcast episodes | Feb 15 2024 Wu Tsai Neurosciences Institute OCD and Ketamine This week, we're taking a deep dive with psychiatrist Carolyn Rodriguez into the neuroscience of obsessive-compulsive disorder (OCD) and why a single dose of ketamine can erase the disorder for weeks at a time. Image Press coverage | Oct 30 2023 Medscape Ketamine No Better for Depression Than Placebo? Ketamine was no more effective than placebo in reducing depressive symptoms in surgical patients with major depression, results of a new study, which contradict prior research, suggest. Image Podcast episodes | Jan 26 2023 Wu Tsai Neurosciences Institute Psychedelics and Empathy Rob Malenka answers: "Why are psychiatrists taking a fresh look at MDMA?" Image Research news | Jan 9 2023 Wu Tsai Neurosciences Institute The rebirth of psychedelic medicine Researchers at the Wu Tsai Neurosciences Institute are at the forefront of a seismic shift that’s putting a spotlight on once taboo psychedelic substances as a promising new frontier in psychiatric medicine. Image Press coverage | Aug 29 2018 NPR Ketamine, A Promising Depression Treatment, Seems To Act Like An Opioid A new study suggests that ketamine, an increasingly popular treatment for depression, has something in common with drugs like fentanyl and oxycodone.
Image News Features | Jul 10 2025 Stanford H&S Foundational research on brain development may help prevent degeneration Stanford neurobiologist Carla Shatz, famous for discovering how neural connections develop early in life, is using that knowledge to work on the problem of how they can later deteriorate from Alzheimer’s disease.
Image Research news | Jul 9 2025 Stanford Medicine People with ‘young brains’ outlive ‘old-brained’ peers A blood-test analysis developed at Stanford Medicine can determine the “biological ages” of 11 separate organ systems in individuals’ bodies and predict the health consequences.
Image Researcher profiles | Jun 23 2025 Stanford Report ‘You can literally lose who you are’ Scientists in the lab of chemical engineer Monther Abu-Remaileh are uncovering the cellular functions that go awry in degenerative brain disorders and identifying therapies that could treat them.
Image News Features | Jun 17 2025 Wu Tsai Neurosciences Institute Myelin matters A decade ago, three generations of Stanford scientists banded together to publish a landmark study on one of the brain’s most prevalent structures. Today, Wu Tsai Neurosciences Institute researchers are discovering that myelin is key to just about every aspect of neurological health.
Image Podcast episodes | Feb 15 2024 Wu Tsai Neurosciences Institute OCD and Ketamine This week, we're taking a deep dive with psychiatrist Carolyn Rodriguez into the neuroscience of obsessive-compulsive disorder (OCD) and why a single dose of ketamine can erase the disorder for weeks at a time.
Image Press coverage | Oct 30 2023 Medscape Ketamine No Better for Depression Than Placebo? Ketamine was no more effective than placebo in reducing depressive symptoms in surgical patients with major depression, results of a new study, which contradict prior research, suggest.
Image Podcast episodes | Jan 26 2023 Wu Tsai Neurosciences Institute Psychedelics and Empathy Rob Malenka answers: "Why are psychiatrists taking a fresh look at MDMA?"
Image Research news | Jan 9 2023 Wu Tsai Neurosciences Institute The rebirth of psychedelic medicine Researchers at the Wu Tsai Neurosciences Institute are at the forefront of a seismic shift that’s putting a spotlight on once taboo psychedelic substances as a promising new frontier in psychiatric medicine.
Image Press coverage | Aug 29 2018 NPR Ketamine, A Promising Depression Treatment, Seems To Act Like An Opioid A new study suggests that ketamine, an increasingly popular treatment for depression, has something in common with drugs like fentanyl and oxycodone.
